4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Veradermics, Incorporated (MANE) operates in the Biotechnology industry and is headquartered in New Haven, United States with about 24 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, MANE reported $0M in revenue and ($70M) in net income.
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | $0M |
| Operating Income (EBIT) | ($72M) | ($26M) | ($17M) |
| Net Income | ($70M) | ($26M) | ($16M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($30M) | ($23M) | ($13M) | ($6M) |
| Net Income | ($27M) | ($22M) | ($12M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $153M | $56M | $18M |
| Total Liabilities | $274M | $104M | $40M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MANE viewer.
About TickerBase · Data methodology & sources